Miki Takemura, MS

Associate Director, Laboratory for Drug Discovery and Disease Research
Shionogi & Co., Ltd.

Miki Takemura, MS, Associate Director, Laboratory for Drug Discovery and Disease Research, SHIONOGI & CO., LTD.
I have been engaged in antibacterial drug research for 12 years at SHIONOGI & CO., LTD., located in Osaka, Japan.
In recent years, I have been in charge of non-clinical pharmacology of a novel siderophore cephalosporin, cefierocol.

Disclosure: Shionogi & Co., Ltd. (Individual(s) Involved: Self): Employee

Presentation(s):

• 164 - in Vitro Antibacterial Activity of Cefiderocol Against Non-fermenter Clinical Strains Collected in North America and Europe from Multinational Surveillance Studies SIDERO-WT-2014–2018

  Oral Abstract

• 165 - Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study

  Oral Abstract